E-LIB Suche - Ergebnisse für: Tseng, Jeng-Sen

1

Attenuation of PI3K-Akt-mTOR Pathway to Reduce Cancer Stemn..:

Huang, Yen-Hsiang ; Chiu, Ling-Yen ; Tseng, Jeng-Sen...
International Journal of Molecular Sciences. 25 (2024) 1 - p. 616 , 2024

Link: https://doi.org/10.3390/..

2

Primary tumor consolidative therapy improves the outcomes o..:

Wu, Jia-Jun ; Tseng, Jeng-Sen ; Zheng, Zhe-Rong...
Therapeutic Advances in Medical Oncology. 16 (2024) - p. , 2024

Link: https://doi.org/10.1177/..

3

Low-Dose Computed Tomography Screening in Relatives With a ..:

Wang, Chi-Liang ; Hsu, Kuo-Hsuan ; Chang, Ya-Hsuan...
Journal of Thoracic Oncology. 18 (2023) 11 - p. 1492-1503 , 2023

Link: https://doi.org/10.1016/..

4

The Role of Neutrophil-to-Lymphocyte Ratio in Advanced EGFR..:

Chen, Kuan-Chih ; Huang, Yen-Hsiang ; Hsu, Kuo-Hsuan...
OncoTargets and Therapy. 16 (2023) - p. 317-326 , 2023

Link: https://doi.org/10.2147/..

5

Outcome of Thromboembolic Events and Its Influence on Survi..:

Ou, Wei-Fan ; Liao, Pei-Ya ; Hsu, Yu-Wei...
Cancer Management and Research. 15 (2023) - p. 1251-1262 , 2023

Link: https://doi.org/10.2147/..

6

Adjuvant chemotherapy compared with observation in patients..:

Lee, Po-Hsin ; Chiang, Chun-Ju ; Tseng, Jeng-Sen...
Frontiers in Oncology. 13 (2023) - p. , 2023

Link: https://doi.org/10.3389/..

7

PD-L1 strong expressions affect the clinical outcomes of os..:

Hsu, Kuo-Hsuan ; Tseng, Jeng-Sen ; Yang, Tsung-Ying...
Scientific Reports. 12 (2022) 1 - p. , 2022

Link: https://doi.org/10.1038/..

8

The Difference in Clinical Outcomes Between Osimertinib and..:

Huang, Yen-Hsiang ; Hsu, Kuo-Hsuan ; Tseng, Jeng-Sen...
Targeted Oncology. 17 (2022) 3 - p. 295-306 , 2022

Link: https://doi.org/10.1007/..

9

Reactivation of Hepatitis B Virus in Lung Cancer Patients R..:

Lee, Po-Hsin ; Huang, Yen-Hsiang ; Hsu, Yu-Wei...
Journal of Clinical Medicine. 12 (2022) 1 - p. 231 , 2022

Link: https://doi.org/10.3390/..

10

Histological Transformation after Acquired Resistance to th..:

Lee, Po-Hsin ; Huang, Yen-Hsiang ; Lin, Ho...
Medicina. 58 (2022) 7 - p. 908 , 2022

Link: https://doi.org/10.3390/..

11

The Clinical Outcomes of Different First-Line EGFR-TKIs Plu..:

Huang, Yen-Hsiang ; Hsu, Kuo-Hsuan ; Chin, Chun-Shih...
Cancer Research and Treatment. 54 (2022) 2 - p. 434-444 , 2022

Link: https://doi.org/10.4143/..

12

Various impacts of driver mutations on the PD-L1 expression..:

Chu, Cheng-Hsiang ; Huang, Yen-Hsiang ; Lee, Po-Hsin...
PLOS ONE. 17 (2022) 8 - p. e0273207 , 2022

Link: https://doi.org/10.1371/..

13

Influence of the Timing of Leptomeningeal Metastasis on the..:

Liao, Pei-Ya ; Ou, Wei-Fan ; Su, Kang-Yi...
Cancers. 14 (2022) 12 - p. 2824 , 2022

Link: https://doi.org/10.3390/..

14

Characteristics and immune checkpoint inhibitor effects on ..:

Wu, Jia-Jun ; Lee, Po-Hsin ; Zheng, Zhe-Rong...
Medicine. 101 (2022) 24 - p. e29381 , 2022

Link: https://doi.org/10.1097/..

15

Correction to: The Difference in Clinical Outcomes Between ..:

Huang, Yen-Hsiang ; Hsu, Kuo-Hsuan ; Tseng, Jeng-Sen...
Targeted Oncology. 18 (2022) 1 - p. 179-180 , 2022

Link: https://doi.org/10.1007/..